Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288952-25-000004
Filing Date
2025-12-18
Accepted
2025-12-18 17:20:05
Documents
1
Period of Report
2025-12-16

Document Format Files

Seq Description Document Type Size
1 form4-12182025_051201.html 4  
1 form4-12182025_051201.xml 4 5329
  Complete submission text file 0001288952-25-000004.txt   6843
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 WASHINGTON STREET SUITE 1300 CONSHOHOCKEN PA 19428
Business Address
SCHMERTZLER MICHAEL (Reporting) CIK: 0001288952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 251584048